Results 51 to 60 of about 97,918 (341)
The Nanomedicines Alliance: An Industry Perspective on Nanomedicines
Journal of Nanomedicine & Nanotechnology, 2014 The field of nanomedicines has expanded significantly in recent years in the breadth of compounds under development as well as in the types of technology that are being applied to generate nanomedicines. The pathway to licensure of new nanomedicines is sufficiently well defined by existing regulations and guidance.
openaire +4 more sources
Drug Delivery, 2018 Epithelial to mesenchymal transition (EMT) has emerged as a key process in the development of renal fibrosis. In fact, EMT-derived fibroblasts contribute to the progression of chronic renal disease.
Anna Sola +8 more
doaj +1 more source
Nanomedicines for the Delivery of Biologics [PDF]
Pharmaceutics, 2019 A special symposium of the Academy of Pharmaceutical Sciences Nanomedicines Focus Group reviewed the current status of the use of nanomedicines for the delivery of biologics drugs. This meeting was particularly timely with the recent approval of the first siRNA-containing product Onpattro™ (patisiran), which is formulated as a lipid nanoparticle for ...
John Wahlich +10 more
openaire +7 more sources
Bionanomedicine: A “Panacea” In Medicine?
Makara Journal of Health Research, 2017 Recent advances in nanotechnology, biotechnology, bioinformatics, and materials science have prompted novel developments in the field of nanomedicine. Enhancements in the theranostics, computational information, and management of diseases/disorders are ...
Dito Anurogo +2 more
doaj +1 more source
Introduction to Nanomedicine [PDF]
Molecules, 2015 Although mentions of nanoparticles in relation to biomedicine appeared in the late 1970s and are now the subject of over 10,000 publications per year, the term “Nanomedicine” only appeared at the turn of this century, and less than 30 papers including this term were published up to 2005. [...]
openaire +3 more sources
Journal of Controlled Release, 2010 Novel nanomaterials are being developed to improve diagnosis and therapy of diseases through effective delivery of drugs, biopharmaceutical molecules and imaging agents to target cells in disease sites. Such diagnostic and therapeutic nanomaterials, also termed “nanomedicines”, often require site-specific cellular entry to deliver their payload to sub ...
Daria Y. Alakhova +3 more
openaire +4 more sources
Reflections on Emerging Technologies in Nanomedicine
Erciyes Medical Journal, 2020 Nanomedicine technologies seem to play an increasing role in modern medicine. Although there are many challenges, it is important to consider emerging technologies that may impact nanomedicine. To establish a rational basis for such consideration in this
Munis Dündar +6 more
doaj +1 more source
Network of nanomedicine researches: impact of Iranian scientists [PDF]
BioImpacts, 2015 Introduction: We may define the nanomedicine as the use of nanotechnology in the health care, disease diagnoses and treatment in order to maintain and increase the health status of a population through improve pharmacotherapy.
Mohammad-Hossein Biglu, Shukuh Riazi
doaj +1 more source
Theranostics, 2020 Following its discovery more than 30 years ago, the enhanced permeability and retention (EPR) effect has become the guiding principle for cancer nanomedicine development.
Yang Shi +3 more
semanticscholar +1 more source
Nanomedicine-based commercial formulations: current developments and future prospects
Journal of Pharmaceutical Investigation, 2022 Background In recent decades, there has been a considerable increase in the number of nanomedicine-based formulations, and their advantages, including controlled/targeted drug delivery with increased efficacy and reduced toxicity, make them ideal ...
R. Thapa, Jong Oh Kim
semanticscholar +1 more source